SCHEMBL6063863

SCHEMBL6063863

CC(C)CC(C(=O)NC(CCc1ccccc1)C(=O)c1nc(C(=O)NCc2ccccc2)co1)N(Cc1ccccc1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 2/20 0.41
PSMB5 P28074 2/20 0.41
NFKB2 Q00653 2/20 0.41
RELA Q04206 2/20 0.41
MMP8 P22894 8/20 0.39
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ANPEP P15144 1/20 0.38
MMP3 P08254 1/20 0.38
CTSL P07711 2/20 0.38
CTSB P07858 1/20 0.37
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6063695 0.84 DAGLA (0.38) PSMB5MMP8ALDH1A1CTSLCTSB
SCHEMBL6063868 0.82 PSMB5 (0.44) NFKB1PSMB5NFKB2RELAMMP8
SCHEMBL6463220 0.82 CTSL (0.51) MMP3CTSLCTSBCTSSCTSK
SCHEMBL6464784 0.79 ANPEP (0.48) NFKB1PSMB5NFKB2RELAMMP8
SCHEMBL6477967 0.78 MMP3 (0.44) MMP8ANPEPMMP3CTSLCTSB
SCHEMBL6466269 0.78 MMP9 (0.44) NFKB1PSMB5NFKB2RELAMMP8
SCHEMBL6466271 0.78 MMP9 (0.44) NFKB1PSMB5NFKB2RELAMMP8
SCHEMBL6464783 0.78 MMP9 (0.44) NFKB1PSMB5NFKB2RELAMMP8
SCHEMBL6463671 0.76 REN (0.47) ALDH1A1ANPEPMMP3CTSLCTSB
SCHEMBL7529166 0.76 KMT2A (0.42) NFKB1PSMB5NFKB2RELAANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed